Sonoma Pharmaceuticals (SNOA) Other financing activities (2011 - 2025)
Sonoma Pharmaceuticals (SNOA) posted quarterly Other financing activities of $21000.0 for Q3 2025, down 19.23% year-over-year from $26000.0 in Q3 2024, and down 8.7% quarter-over-quarter from $23000.0 in Q2 2025.
Sonoma Pharmaceuticals (SNOA) Other financing activities (2011 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Other financing activities history runs 13 years deep, the most recent figure standing at $21000.0 for Q3 2025.
- In Q3 2025, Other financing activities fell 19.23% year-over-year to $21000.0; the TTM figure through Mar 2026 stood at $44000.0 (down 46.34% YoY), while the FY2026 annual figure was $44000.0, down 46.34% from the prior year.
- Other financing activities for Q3 2025 stood at $21000.0, down from $23000.0 in the prior quarter.
- The five-year high for Other financing activities was $2.3 million in Q1 2021, with the low at $7000.0 in Q2 2024.
- The 3-year median for Other financing activities is $26000.0 (2024), against an average of $381857.1.
- The sharpest annual moves came in 2021 and 2025: Other financing activities soared 4762.0% in 2021, then fell 19.23% in 2025.
- Sonoma Pharmaceuticals' Other financing activities stood at $216000.0 in 2021, then plunged by 87.96% to $26000.0 in 2024, then dropped by 19.23% to $21000.0 in 2025.
- Business Quant data shows SNOA's Other financing activities at $21000.0 in Q3 2025, $23000.0 in Q2 2025, and $49000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 21,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Sep 30, 2021 | 216,000.00 |
| Sep 30, 2021 | 216,000.00 |
| Mar 31, 2021 | 2.33 Mn |
| Mar 31, 2021 | 2.33 Mn |
| Dec 31, 2020 | -6,000.00 |
| Dec 31, 2020 | -6,000.00 |
| Sep 30, 2020 | -1.53 Mn |
| Sep 30, 2020 | -1.53 Mn |
| Jun 30, 2020 | 1.49 Mn |
| Jun 30, 2020 | 1.49 Mn |